Compare SON & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SON | TMDX |
|---|---|---|
| Founded | 1899 | 1998 |
| Country | United States | United States |
| Employees | N/A | 728 |
| Industry | Containers/Packaging | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.2B |
| IPO Year | N/A | 2019 |
| Metric | SON | TMDX |
|---|---|---|
| Price | $44.39 | $122.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $56.83 | ★ $144.25 |
| AVG Volume (30 Days) | ★ 886.5K | 664.3K |
| Earning Date | 02-17-2026 | 10-29-2025 |
| Dividend Yield | ★ 4.86% | N/A |
| EPS Growth | 116.52 | ★ 170.70 |
| EPS | ★ 6.30 | 2.54 |
| Revenue | ★ $7,114,053,000.00 | $566,354,000.00 |
| Revenue This Year | $45.34 | $38.81 |
| Revenue Next Year | N/A | $20.49 |
| P/E Ratio | ★ $23.56 | $47.97 |
| Revenue Growth | ★ 67.86 | 41.20 |
| 52 Week Low | $38.65 | $55.00 |
| 52 Week High | $50.09 | $156.00 |
| Indicator | SON | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 69.19 | 42.49 |
| Support Level | $42.96 | $121.00 |
| Resistance Level | $44.10 | $133.29 |
| Average True Range (ATR) | 0.66 | 4.77 |
| MACD | 0.09 | -0.84 |
| Stochastic Oscillator | 97.01 | 21.89 |
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.